Remarks on sentinel node biopsy in head and neck cancer by Kovács, A F
Letters to the Editor
Remarks on sentinel node biopsy in head and neck cancer
AF Kova ´cs*,1
1Universitatsklinik Haus 21 Klinik und Poliklinik fur Kiefer- und Plastische Gesichtschirurgie, Theodor-Stern-Kai 7, Frankfurt am Main D-60590, Germany
British Journal of Cancer (2005) 92, 206–207. doi:10.1038/sj.bjc.6602293 www.bjcancer.com
Published online 14 December 2004
& 2005 Cancer Research UK
                
Sir,
The status of the regional lymphatics is one of the most
important prognostic parameters in patients with head and neck
cancer, and the presence or absence, level, and size of metastatic
neck disease are crucial for treatment and survival. Due to the
limited sensitivity and specificity of the usual diagnostic tools like
ultrasound, CT, MRI, and PET (Stuckensen et al, 2000), a
pathohistological staging of the neck was generally adopted to
remove and detect occult metastases, which could not be detected
by these imaging techniques. A large number of elective neck
dissections (ND) where the pathohistological examination of the
surgical neck specimen did not reveal any positive nodes was
accepted. This surgical procedure was associated with risks and
morbidity of the patients concerned.
In the last years, beginning with a case report by Alex and Krag
(1996), sentinel node biopsy (SNB) in head and neck cancer
became a very interesting field of clinical investigation. Other
investigators followed, and the recent article of Ho ¨ft et al (2004)
mentioned some of them. Because the method of SNB was
interlaced with the N0 neck, that is, a neck without clinically
detectable nodal metastasis, the procedure generally adopted by
investigators like Ho ¨ft et al (2004) was to carry out an elective ND
parallely to SNB. The pathohistological results were compared,
with the sentinel nodes carrying metastasis being the false-negative
results of the imaging techniques. Experience still is limited,
follow-up too short. We felt, however, that Ho ¨ft et al (2004) did not
discuss some relevant topics in depth.
The first problem is the definition of the N0 neck, in other words
the method of examination on which the clinical diagnosis was
based. Ho ¨ft et al (2004) based staging of the neck on ultrasound
examination and had a rate of 24% positive sentinel nodes in 50
patients. Contributors to the first multicentre study on sentinel
node biopsy in head and neck cancer (Ross et al, 2004) based their
staging on either clinical palpation or radiological imaging
techniques like CT and had an upstaging rate of 34% in 134
patients. Kova ´cs et al (2001, 2004a,c) had an upstaging rate of 5-
15% following neck staging based on PET in 15 and 38 patients.
Thus, SNB reflected the accuracy of the clinical and radiological
staging methods, and the ideal diagnostic prerequisite for SNB is
not yet found.
The second problem is the dimension of the primary. Ho ¨ft et al
(2004) stated that ‘if a complete peritumoral injection of the tracer
is not possible, the patient is not eligible for the sentinel node
method’. We agree that peritumoral accessibility is more
important than T classification, but large T3 and T4 primaries
pose problems due to destroyed lymphatic drainage. Local intra-
arterial induction chemotherapy, however, did not seem to alter
lymphatic drainage (Kova ´cs et al, 2004b) and might be a modality
of treatment that can be added prior to SNB reducing tumour size.
The third and main problem is the omission of an elective ND,
which would potentially achieve a benefit for the patient
concerning risk, morbidity, and life quality. This would depend
on the reliability of SNB. In the study of Ho ¨ft et al (2004), ‘no
patient with tumor-free sentinel nodes was found to have a
metastasis in a nonsentinel lymph node’. False-negative results
have been very rare in all previous studies, too. This would
encourage the omission of elective ND in favour of SNB. However,
Ho ¨ft et al (2004) falsely stated that ‘So far, only Ross et al (2002)
have reported on a study of a true biopsy of the sentinel lymph
node without elective neck dissection’. Kova ´cs et al (2001)
reported on true biopsy of the sentinel node without elective
ND, and all consecutive patients have been treated that way
(Kova ´cs et al, 2001, 2004a–c). Diagnostics using PET in
combination with SNB considerably reduced the number of
elective ND, and the inconspicuous follow-up time of 80 patients
to date surpassing a median of 2 years makes it not likely that this
will be paired with hazard. Some contributors of the mentioned
multicentre study also adopted this procedure, and there is hope
that SNB without elective ND will be the staging procedure of the
future in a large number of head and neck cancer patients.
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Sir,
Thank you for giving us the opportunity to respond to the
commentary letter by Dr Kovacs.
In the third paragraph, Dr Kovacs is referring to staging
methods. He compares four publications (Kovacs et al, 2001,
2004a,c; Ross et al, 2004) to our present publication in the British
Journal of Cancer (Ho ¨ft et al, 2004). One of the four studies was
published after ours (Ross et al, 2004). Two are not published yet,
but are in press (Kovacs et al, 2004a,c). Dr Kovacs’ conclusion that
‘sentinel lymph node biopsy reflected the accuracy of the clinical
and radiological staging methods, and the ideal diagnostic
prerequisite for SNB is not yet found’ is quite similar to ours,
namely the ‘better the staging methods are in detecting small
metastases the less occult metastases will be overlooked and the
more valuable will be the impact of an additional sentinel lymph
node procedure’. However, the rate of positive sentinel lymph
nodes is not only influenced by the staging procedure but also by
the pathohistologic work-up. The more the intensive sentinel
lymph nodes are examined, the more the occult metastases will be
detected, raising the percentage of patients with occult disease
(Ho ¨ft et al, 2002; Ho ¨ft et al, 2004). In our study, we applied
ultrasound examinations for staging of the neck as a radiological
method and also performed fine-needle aspiration cytologies. The
accuracy of US-guided aspiration cytology has been shown to be
significantly better than that of CT or MRI (van den Brekel et al,
1991).
The fourth paragraph concerns the obstacle of performing a
sentinel node biopsy on large tumours. In our group of patients,
this is due to the fact that it was difficult to perform an endoscopic
peritumoral injection on large tumours located in the pharynx and
the larynx (Ho ¨ft et al, 2004). Dr Kovacs adds that large tumours
pose problems due to destruction of the lymphatic drainage, but he
fails to provide data or literature on which his opinion is based. As
we did not perform histologic studies of the lymphatics, we cannot
add new information whether large tumours are more aggressive
in destroying lymphatic vessels on their rim than are small
tumours. However, the technique of the peritumoral injection is to
inject the tracer adjacent to, and not into, the tumour. Thus, it does
not really matter if a tumour destroys lymphatic vessels within its
borders, as there will be intact lymphatics surrounding the tumour
to take up the tracer even in large carcinomas.
In his last sentence of the fourth paragraph, Dr Kovacs suggests
that an intra-arterial induction chemotherapy might be a modality
in reducing tumour size prior to sentinel node biopsy. It is an
interesting suggestion we would have liked to discuss in our
article. However, Dr Kovacs’ results were still in press when his
letter of comment was written. Thus, the information he refers to
was not accessible to us. Yet, although Dr Kovacs states that intra-
arterial chemotherapy did not seem to alter lymphatic drainage
(Kovacs et al, 2004b), there is ample evidence that preoperative
chemotherapy affects lymph nodes. Cohen et al (2000) describe
lymph nodes showing areas of fibrosis, fat necrosis, histiocytic
accumulation and granulation formation after neoadjuvant che-
motherapy. Furthermore, metastatic foci can be completely
obliterated by chemotherapy. Accordingly, Nason et al (2000)
concluded in their study that preoperative chemotherapy is
associated with an unacceptable high false negative rate for
sentinel lymph node detection. If these changes are evident in
chemotherapy, we would expect to find them in patients with
intra-arterial chemotherapy, too. We are looking forward to the
publication of Dr Kovacs’ results and histologic findings of the
lymphatics.
In the fifth paragraph, Dr Kovacs refers to the omission of an
elective neck dissection potentially achieving a benefit for the *Correspondence: Dr S Hoft, E-mail: hoft@hno.uni-kiel.de
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